Valuation: Simulations Plus, Inc.

Market Cap 37Cr 32Cr 30Cr 28Cr 52Cr 3.54TCr 53Cr 357.42Cr 140.36Cr 1.74TCr 139.21Cr 136.18Cr 5.99TCr P/E 2026 *
43.9x
P/E 2027 * 40.5x
Enterprise Value 37Cr 32Cr 30Cr 28Cr 52Cr 3.54TCr 53Cr 357.42Cr 140.36Cr 1.74TCr 139.21Cr 136.18Cr 5.99TCr EV / Sales 2026 *
4.53x
EV / Sales 2027 * 4.3x
Free-Float
82.79%
Yield 2026 *
-
Yield 2027 * -
1 day-0.52%
1 week-0.63%
Current month-0.35%
1 month+14.46%
3 months+39.92%
6 months-3.52%
Current year+0.08%
1 week 18.22
Extreme 18.22
18.45
1 month 15.67
Extreme 15.67
18.68
Current year 11.09
Extreme 11.09
21.01
1 year 11.09
Extreme 11.09
21.01
3 years 11.09
Extreme 11.09
52.69
5 years 11.09
Extreme 11.09
67.59
10 years 7.44
Extreme 7.44
90.92
Manager TitleAgeSince
Chief Executive Officer 67 26/06/2018
Director of Finance/CFO 63 01/12/2020
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 81 17/07/1996
Chairman 76 17/12/2024
Director/Board Member 58 03/12/2014
Date Insider Type Main position Quantity % Market Cap.
06/07Sell

Executive/Senior Manager

-1,000 0.0050%
01/07Sell

Founder

-4,177 0.0207%
16/06Fiscal year

Executive/Senior Manager

22,050 0.1094%
Change 5-day change 1-year change 3-year change Capi.($)
-0.52%-0.63%+3.84%-58.46% 37Cr
+0.30%-0.96%-32.48%-4.84% 3.08TCr
-6.34%-4.30%-37.37%+213.11% 1.53TCr
-0.77%-4.53%-20.85%+62.11% 567.58Cr
-3.75%-1.48% - - 239.06Cr
-2.28%-1.01%+50.44%-38.09% 207.34Cr
-9.38%-15.51% - - 201.52Cr
-0.98%-12.26%-30.95% - 110.36Cr
-8.46%-5.43%+43.29%+107.96% 101.53Cr
+0.60%+0.69%-33.62%+306.25% 83Cr
Average -3.17%-1.23%-7.21%+84.01% 615.47Cr
Weighted average by Cap. -2.16%-0.77%-28.03%+66.34%

Financials

2026 *2027 *
Net sales 8.19Cr 7.16Cr 6.6Cr 6.1Cr 12Cr 780.78Cr 12Cr 79Cr 31Cr 384.64Cr 31Cr 30Cr 1.32TCr 8.63Cr 7.54Cr 6.96Cr 6.43Cr 12Cr 822.66Cr 12Cr 83Cr 33Cr 405.27Cr 32Cr 32Cr 1.39TCr
Net income 92.3L 80.73L 74.47L 68.78L 1.31Cr 88Cr 1.33Cr 8.9Cr 3.49Cr 43Cr 3.47Cr 3.39Cr 149.08Cr 97.09L 84.93L 78.33L 72.35L 1.37Cr 93Cr 1.4Cr 9.36Cr 3.68Cr 46Cr 3.65Cr 3.57Cr 156.83Cr
Net Debt - -
Logo Simulations Plus, Inc.
Simulations Plus, Inc. specializes in model-informed and artificial intelligence (AI)-accelerated drug development. The Company helps its clients by accelerating the discovery, development, and commercialization of pharmaceuticals and other products through science-based software and consulting solutions. The Company’s segments include Software and Services. The Company's Software segment supports pharmaceutical research, development, and commercialization through simulation, modeling, and AI-driven prediction. Its main products include GastroPlus, ADMET Predictor, MonolixSuite, and others for disease modeling and training, as well as Pro-ficiency for clinical operations. Its Services segment includes advanced consulting services across the entire drug development lifecycle. Its scientists and engineers specialize in drug discovery, pharmacokinetics, pharmacodynamics, drug modeling, clinical trial data analysis, regulatory strategy, and medical communications.
Employees
213
Date Price Change Volume
10/26/10 $18.25 -0.52% 1,66,883
09/26/09 $18.34 +0.38% 4,03,218
08/26/08 $18.27 -0.05% 3,97,537
07/26/07 $18.28 -0.44% 3,52,032
06/26/06 $18.36 -0.16% 3,40,704
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
18.34USD
Average target price
17.25USD
Spread / Average Target
-5.94%

Quarterly revenue - Rate of surprise